Convenient synthesis of α-nitrooximes mediated by OXONE®

Napasawan Chumnanveja, Natthapol Samakkanada, Manat Pohmakotra, Vichai Reutrakula, Thaworn Jaipetchb, Darunee Soorukrama and Chutima Kuhakarn*a
aDepartment of Chemistry and Center of Excellence for Innovation in Chemistry (PERCH-CIC), Faculty of Science, Mahidol University, Rama VI Road, Bangkok 10400, Thailand
bMahidol University, Kanchanaburi Campus, Saiyok, Kanchanaburi 71150, Thailand

Received 3rd October 2014 , Accepted 28th October 2014

First published on 28th October 2014


Abstract

A novel OXONE® mediated direct difunctionalization of alkenes with NaNO2 in aqueous acetonitrile for the synthesis of α-nitrooximes was developed. The α-nitrooximes were readily prepared in moderate to high yields at room temperature under mild reaction conditions. The present protocol offers an easy and environmentally benign approach to access various α-nitrooximes derived from styrene derivatives.


Introduction

1,2-Difunctionalizations of the carbon–carbon double bonds in alkenes are among the most powerful transformations in chemical synthesis. They are challenging synthetic transformations in organic chemistry, used for the introduction of functional groups into an unactivated alkene moiety as well as for the enhancement of molecular complexity. In recent years, novel metal-catalyzed and metal-free methods for the difunctionalization of alkenes have been reported, such as dioxygenation,1 oxyamination,2 oxythiolation,3 oxyphosphorylation,4 and diamination.5 In particular, the introduction of two vicinal carbon–nitrogen bonds provides powerful access to vicinal diamines which are important scaffolds found in pharmaceutically important compounds, materials and ligands in catalysis (Fig. 1).6 Therefore, the development of new reactions that allow direct access for the formation of C–N bonds from alkenes has long been a challenge of interest to the synthetic community.
image file: c4ra11703d-f1.tif
Fig. 1 Representative examples of some important compounds containing the diamine moiety.

In contrast to the synthesis of oximes from alkenes,7 the synthesis of α-nitrooximes has been less studied (Scheme 1).8 Scheinbaum employed the reaction of olefins with nitrous anhydride (N2O3) generated by the reaction of nitric oxide and air, followed by the treatment of the initially obtained pseudonitrosites with ZnCl2 (Scheme 1, Path A).8c The preformed peroxynitrite-promoted reaction of styrene, leading to a mixture of α-nitrooxime, nitrate, benzaldehyde, α-nitroacetophenone and a nitroalkene was reported by Grossi (Scheme 1, Path B).8b Also, a solvent-free synthesis of pseudonitrosites, which can undergo tautomerization to α-nitrooxime, was reported by Shaabani and co-workers (Scheme 1, Path C).8a Despite significant developments, available methods toward α-nitrooxime synthesis required gaseous reagents or tedious experimentations for the preparation of the requisite reagent.8c,9 With continuous research efforts aiming at 1,2-difunctionalizations of alkenes and alkynes,10 we report herein an alternative, convenient and efficient synthesis of α-nitrooximes from alkenes by employing commercially available reagents (NaNO2 and OXONE®) (Scheme 1). OXONE® is found in many synthetic applications, due to its stability, high efficiency and mild reaction conditions, as well as the minimization of organic chemical waste.11


image file: c4ra11703d-s1.tif
Scheme 1 Methods for α-nitrooxime synthesis.

Results and discussion

Initially, the reaction of 4-bromostyrene (1a) with NaNO2/OXONE® was chosen as a model reaction in order to find the optimized reaction conditions. The selected results of the optimization experimentation are summarized in Table 1. In a typical reaction procedure, 1a, NaNO2 (half of the total amount employed) and OXONE® were suspended in an organic solvent, followed by the slow addition of water. After the reaction was stirred at room temperature for 45 min, a second half portion of NaNO2 was added and the reaction was further stirred for an additional 45 min. After chromatographic purification by column chromatography, the corresponding α-nitrooxime 2a was isolated as a single isomer (1H NMR analysis) along with a nitroalkene 3a (E isomer) as a competing product. The α-nitrooxime 2a and nitroalkene 3a could be readily separated by simple column chromatography. In the initial experiment, 1a was allowed to react with NaNO2 (4 equiv.) and OXONE® (2 equiv.). A screening of the solvents indicated that a combination of acetonitrile and water gave the best results, affording the desired α-nitrooxime 2a in 84% isolated yield (Table 1, entries 1–8). When the reactions were carried out with a lower ratio of water to CH3CN, lower yields of 2a were obtained (Table 1, entry 9). The reaction was less efficient upon a decrease or increase of the amount of either NaNO2 or OXONE® employed (Table 1, entries 10–13). It is worth mentioning that in the reactions shown in Table 1, entry 8 was carried out by employing a single portion of NaNO2 (4 equiv.) in the reaction vessel; a vigorous reaction took place with the observation of heat generation as well as fuming of brownish gaseous species.
Table 1 Reaction optimizationa

image file: c4ra11703d-u1.tif

Entry OXONE® NaNO2 Solvent Yieldb (%)
(equiv.) (equiv.) (v/v) 2ac 3a
a Reaction conditions: 1a (0.5 mmol), NaNO2 (half of the total amount employed), and OXONE® were suspended in an organic solvent, followed by the slow addition of water. After the reaction was stirred at room temperature for 45 min, a second half portion of NaNO2 was added and the reaction was further stirred for an additional 45 min.b Isolated yield.c In all cases, 2a was obtained as a single isomer after chromatographic purification.
1 2 4 CH2Cl2[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]2) 37 8
2 2 4 ClCH2CH2Cl[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]2) 40 19
3 2 4 EtOAc[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]2) 52 7
4 2 4 Acetone[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]2) 55 10
5 2 4 Toluene[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]2) 43 13
6 2 4 iPrOH[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]2) 22
7 2 4 MeOH[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]2)
8 2 4 CH3CN[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]2) 84 6
9 2 4 CH3CN[thin space (1/6-em)]:[thin space (1/6-em)]H2O (2[thin space (1/6-em)]:[thin space (1/6-em)]1) 68 5
10 2 2 CH3CN[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]2) 9 10
11 2 3 CH3CN[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]2) 44 2
12 1 4 CH3CN[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]2) 47 19
13 4 4 CH3CN[thin space (1/6-em)]:[thin space (1/6-em)]H2O (1[thin space (1/6-em)]:[thin space (1/6-em)]2) 45 13


With the above optimal reaction conditions in hand (Table 1, entry 8), the scope and limitations of the reaction were evaluated by employing a range of structurally different styrene derivatives. It should be noted that, except for 2r, the α-nitrooximes were obtained as a mixture of two isomers (1H NMR analysis of the crude mixtures or after chromatographic purification). Upon column chromatographic purification, in some cases, the α-nitrooximes were isolated as a single isomer. The results are summarized in Table 2. Halogen-substituted styrene derivatives including Br, Cl and F at the para-, meta-, or ortho-positions gave the corresponding products in moderate to good yields (59–84% yields) (Table 2, entries 1–6). Furthermore, 4-nitrostyrene and 3-nitrostyrene also gave moderate yields (62–66% yields) (Table 2, entries 7 and 8). A sensitive formyl group and a chloromethyl group were found to be well accommodated and each of their corresponding products were obtained as a single isomer (Table 2, entries 9 and 10). Electron-releasing substituted styrenes including 4-Me-, 4-MeO-, and 4-tBu-substituted styrenes appeared less efficient, yielding the corresponding α-nitrooximes in moderate yields (45–59% yields) (Table 2, entries 11–13). 4-Acetoxystyrene afforded its corresponding α-nitrooxime in 71% yield (Table 2, entry 14). Moreover, the reactions involving a simple styrene, 1-vinylnaphthalene, and β-substituted styrene derivatives which include β-methylstyrene and 1,2-dihydronaphthalene, were also successful, yielding the respective products in moderate yields (44–63% yields) (Table 2, entries 15–18). Finally, 2-vinylthiophene gave the corresponding α-nitrooxime derivative in 73% yield (Table 2, entry 19) while 2-vinyl- and 4-vinylpyridines led to unidentified complex mixtures. It should be noted that in all cases, the corresponding nitroalkenes (E isomers) were also obtained in varying quantities (2–21% yields). Unfortunately, the present protocol was found to be incompatible with aliphatic alkenes including 1-octene and cyclohexene; complex mixtures were observed in the TLC analyses with poor mass recovery.

Table 2 Evaluation of scope and limitations of the reactiona

image file: c4ra11703d-u2.tif

Entry Substrate Product; yieldb (%)
Ar = R = α-Nitrooxime, 2 (isomer ratio)c Nitroalkene, 3
a Reaction conditions: 1 (0.5 mmol), NaNO2 (2 equiv.) and OXONE® (2 equiv.) were suspended in CH3CN (1 mL), followed by the slow addition of water (2 mL). After the reaction was stirred at room temperature for 45 min, NaNO2 (2 equiv.) was added and the reaction was further stirred for an additional 45 min.b Isolated yield; in most cases their corresponding nitroalkenes (E isomers) were isolated in the range of 2–21% yields.c The isomeric ratio was determined by 1H NMR analysis.d 1H NMR spectral data of the crude mixtures exhibited a mixture of two isomers; compound (isomer ratio): 2a (11.0[thin space (1/6-em)]:[thin space (1/6-em)]1); 2i (10.5[thin space (1/6-em)]:[thin space (1/6-em)]1); 2j (10[thin space (1/6-em)]:[thin space (1/6-em)]1); 2l (9.2[thin space (1/6-em)]:[thin space (1/6-em)]1); 2o (9.9[thin space (1/6-em)]:[thin space (1/6-em)]1).e A 1H NMR spectrum of the crude mixture exhibited a single isomer.
1 4-BrC6H4 H 2a; 84 (single isomer)d 3a; 6
2 4-ClC6H4 H 2b; 73 (27.6[thin space (1/6-em)]:[thin space (1/6-em)]1) 3b; 10
3 3-ClC6H4 H 2c; 74 (14.4[thin space (1/6-em)]:[thin space (1/6-em)]1) 3c; 3
4 2-ClC6H4 H 2d; 59 (1.7[thin space (1/6-em)]:[thin space (1/6-em)]1) 3d; 6
5 4-FC6H4 H 2e; 69 (11.5[thin space (1/6-em)]:[thin space (1/6-em)]1) 3e; 7
6 3-FC6H4 H 2f; 75 (32.3[thin space (1/6-em)]:[thin space (1/6-em)]1) 3f; 2
7 4-O2NC6H4 H 2g; 66 (19.0[thin space (1/6-em)]:[thin space (1/6-em)]1) 3g; 5
8 3-O2NC6H4 H 2h; 62 (21.2[thin space (1/6-em)]:[thin space (1/6-em)]1) 3h; 3
9 3-OHCC6H4 H 2i; 56 (single isomer)d 3i; 7
10 4-(ClCH2)C6H4 H 2j; 60 (single isomer)d 3j; 7
11 4-MeC6H4 H 2k; 45 (10.8[thin space (1/6-em)]:[thin space (1/6-em)]1) 3k; 21
12 4-MeOC6H4 H 2l; 51 (single isomer)d 3l; 5
13 4-tBuC6H4 H 2m; 59 (5.5[thin space (1/6-em)]:[thin space (1/6-em)]1) 3m; 8
14 4-AcOC6H4 H 2n; 71 (14.4[thin space (1/6-em)]:[thin space (1/6-em)]1) 3n; 9
15 C6H5 H 2o; 63 (single isomer)d 3o; 5
16 1-Naphthyl H 2p; 44 (1.7[thin space (1/6-em)]:[thin space (1/6-em)]1) 3p; 15
17 C6H5 CH3 2q; 52 (2.3[thin space (1/6-em)]:[thin space (1/6-em)]1) 3q; 12
18 image file: c4ra11703d-u3.tif   2r; 56 (single isomer)e 3r; 0
19 1-Thienyl H 2s; 73 (1[thin space (1/6-em)]:[thin space (1/6-em)]1) 3s; 0


While no detailed mechanistic studies were carried out, to follow the reaction pathway, some control experiments were conducted. Thus, the reaction with p-bromostyrene (1a) was carried out in the presence of radical inhibitors, including TEMPO [(2,2,6,6-tetramethylpiperidin-1-yl)oxyl, 1 equiv.] and BHT (3,5-di-tert-butyl-4-hydroxytoluene, 1 equiv.) (Scheme 2). It was found that the α-nitrooxime 2a was obtained in much lower yields, 19% yield and 32% yield, respectively. Since both the TEMPO and BHT experiments only lower the reaction yields rather than cease the reaction, the control experiments do not fully indicate a radical mechanism. On the basis of previous reports,8b,c a mechanistic proposal is predicted as shown in Scheme 3. Primarily, a nitrite anion is oxidized by OXONE®, generating unstable peroxynitrous acid (HPN, HOONO). Under the reaction conditions (OXONE®, pKa ∼ 2), the peroxynitrous acid decomposes, leading to a reactive species which is believed to be nitrous anhydride (N2O3). Alternatively, sodium nitrite under relatively acidic conditions in situ generates nitrous acid (HNO2) which undergoes decomposition to furnish several electrophilic species including NO, NO2, N2O3 and N2O4. The nitrous anhydride reacts with styrene and its derivatives to generate a more stable benzylic radical A and nitric oxide (NO). Subsequent coupling of the benzylic radical A with nitric oxide then gives a C-nitroso derivative which easily undergoes tautomerization, leading to the observed α-nitrooxime 2. It is believed that the major isomer of α-nitrooxime 2 that was obtained has a Z configuration (the methylnitro group syn to the hydroxy group). In comparison with a closely related system, the 1H NMR signals of the methylene protons of the Z isomer resonate at a lower field than those of the E isomer due to the deshielding effect of the electronegative oxygen atom.12 As the corresponding nitroalkene 3 was isolated as a by-product, it is likely to be derived from the benzylic radical A generating a benzyl cation via a one-electron oxidation with OXONE® followed by a deprotonation process. Although the radical mechanistic pathway shown in Scheme 3 can direct alkenes to α-nitrooximes, we cannot exclude the possibility of the ionic mechanism proceeding via the nitronium ion (+NO2) which acts as a nitrating species. The failure of aliphatic alkenes to undergo the reaction suggests the involvement of the cationic intermediate. The formation of nitroalkene 3 also suggests the involvement of the nitronium ion (+NO2) to serve as a reactive electrophile. Thus, the nitronium ion reacts with the styrene substrates, leading to a benzylic cation B which upon elimination of a proton yields nitroalkene 3 (Scheme 3).


image file: c4ra11703d-s2.tif
Scheme 2 Control experiments.

image file: c4ra11703d-s3.tif
Scheme 3 Plausible reaction pathway.

Conclusion

In summary, we have developed a convenient synthesis of α-nitrooximes from styrene derivatives by employing a new combination of the inorganic salt OXONE® and sodium nitrite. The reaction readily proceeded at ambient temperature and conveniently employed inexpensive and environmentally benign reagents. The reaction offers easy access to the 1,2-difunctionalization of alkenes through the formation of C–N bonds, albeit limited to styrene derivatives.

Experimental

General information

1H NMR spectra were recorded with a Bruker DPX-300 (300 MHz) or a Bruker Ascend™ 400 (400 MHz) spectrometer in CDCl3 using tetramethylsilane as an internal standard or in acetone-d6 using a residual non-deuterated solvent peak as an internal standard. 13C NMR spectra were recorded with a Bruker DPX-300 (75 MHz) or a Bruker Ascend™ 400 (100 MHz) spectrometer in CDCl3 or acetone-d6 using a residual non-deuterated solvent peak as an internal standard. IR spectra were recorded with a Perkin Elmer 683 GX FTIR System spectrometer. High resolution mass spectra were recorded with a Bruker micro TOF spectrometer. Melting points were recorded with a digital Electrothermal Melting 9100 apparatus and uncorrected. Column chromatography was performed using Merck silica gel (Art 7734). Other common solvents (dichloromethane, hexanes, ethyl acetate, and acetone) were distilled before use.

General procedure for the synthesis of α-nitrooxime

A mixture of the styrene derivative (0.5 mmol), sodium nitrite (68.9 mg, 1 mmol) and OXONE® (307.4 mg, 1 mmol) was suspended in acetonitrile (1 mL). To this mixture was slowly added H2O (2 mL) at room temperature. After the reaction mixture was stirred at room temperature for 45 min, a second portion of sodium nitrite (68.9 mg, 1 mmol) was introduced and the resulting mixture was further stirred for an additional 45 min. The reaction mixture was diluted by the addition of water (5 mL) and was extracted with EtOAc (3 × 15 mL). The combined organic layers were washed with H2O (20 mL) and brine (20 mL), dried (anhydrous MgSO4), filtered and vacuumed (aspirator). The residue was purified by column chromatography (SiO2) using acetone/hexanes as the eluent to provide the corresponding product.
1-(4-Bromophenyl)-2-nitroethanone oxime (2a). White solid (109.7 mg, 84% yield); mp = 97–98 °C (CH2Cl2/hexanes); TLC (30% acetone in hexanes) Rf = 0.26; 1H NMR (400 MHz; CDCl3) δ 9.18 (br s, 1H), 7.57 (dd, J = 6.7, 2.0 Hz, 2H), 7.49 (dd, J = 6.7, 2.0 Hz, 2H), 5.62 (s, 2H) ppm. 13C NMR (100 MHz; CDCl3) δ 147.8 (C), 132.3 (2 × CH), 131.9 (C), 127.7 (2 × CH), 125.0 (C), 68.1 (CH2) ppm; IR (KBr) ν 3232 (O–H), 1636 (C[double bond, length as m-dash]N), 1558 and 1375 (NO2) cm−1; MS m/z (%) relative intensity 258 (M+, 55), 181 (57), 169 (100), 102 (59), 89 (73); HRMS (APCI-TOF) calcd for C8H8BrN2O3 [M + H]+ 258.9718, found 258.9719.
1-(4-Chlorophenyl)-2-nitroethanone oxime (2b)8a. Yellow viscous oil (79.6 mg, 73% yield); TLC (30% acetone in hexanes) Rf = 0.29; 1H NMR (400 MHz; CDCl3, isomeric ratio 27.6[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 9.87 (br s, 1H of major and minor isomers), 7.54 (dd, J = 6.8, 2.0 Hz, 2H of major and minor isomers), 7.38 (dd, J = 6.8, 2.0 Hz, 2H of major and minor isomers), 5.62 (s, 1.93H), 5.40* (s, 0.07H) ppm. 13C NMR (100 MHz; CDCl3) δ 147.4 (C), 136.4 (C), 131.4 (C), 129.7* (2 × CH), 129.2 (2 × CH), 128.9* (2 × CH), 127.3 (2 × CH), 77.8* (CH2), 68.1 (CH2) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3235 (O–H), 1596 (C[double bond, length as m-dash]N), 1562 and 1379 (NO2) cm−1; HRMS (APCI-TOF) m/z calcd for C8H8ClN2O3 [M + H]+ 215.0223, found 215.0213.
1-(3-Chlorophenyl)-2-nitroethanone oxime (2c). Yellow viscous oil (79.9 mg, 74% yield); TLC (30% acetone in hexanes) Rf = 0.31; 1H NMR (400 MHz; CDCl3, isomeric ratio 14.4[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 9.39 (br s, 1H of major and minor isomers), 7.63 (t, J = 1.8 Hz, 0.94H), 7.60* (t, J = 1.8 Hz, 0.06H), 7.49–7.34 (m, 3H of major and minor isomers), 5.62 (s, 1.87H), 5.39* (s, 0.13H) ppm. 13C NMR (100 MHz; CDCl3) δ 147.6 (C), 135.1 (C), 134.7 (C), 130.5 (CH), 130.3 (CH), 130.0* (CH), 128.5* (CH), 126.3 (CH), 126.2* (CH), 124.5* (CH), 124.3 (CH), 77.8* (CH2), 68.2 (CH2) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3274 (O–H), 1630 (C[double bond, length as m-dash]N), 1559 and 1373 (NO2) cm−1; MS m/z (%) relative intensity 214 (M+, 6), 137 (100), 125 (68), 102 (64), 75 (40); HRMS (APCI-TOF) calcd for C8H7ClN2NaO3 [M + Na]+ 237.0043, found 237.0041.
1-(2-Chlorophenyl)-2-nitroethanone oxime (2d). Yellow viscous oil (64.0 mg, 59% yield); TLC (30% acetone in hexanes) Rf = 0.31; 1H NMR (400 MHz; CDCl3, isomeric ratio 1.7[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 9.71 (br s, 0.63H), 9.02* (br s, 0.37H), 7.53–7.33 (m, 4H of major and minor isomers), 5.60 (s, 1.25H), 5.42* (s, 0.75H) ppm. 13C NMR (100 MHz; CDCl3) δ 148.8 (C), 147.9* (C), 132.6* (C), 132.5 (C), 131.7 (CH), 131.5 (CH), 131.3 (C), 131.2* (CH), 130.6* (CH), 130.0 (CH), 129.8* (CH), 129.7* (C), 127.5 (CH), 127.0* (CH), 77.4* (CH2), 70.2 (CH2) ppm; IR (neat) ν 3272 (O–H), 1622 (C[double bond, length as m-dash]N), 1558 and 1373 (NO2) cm−1; MS m/z (%) relative intensity 215 (M+ + 1, 100), 137 (31), 102 (41), 75 (19); HRMS (APCI-TOF) calcd for C8H7ClN2NaO3 [M + Na]+ 237.0043, found 237.0042.
1-(4-Fluorophenyl)-2-nitroethanone oxime (2e)8a. Yellow viscous oil (70.0 mg, 69% yield); TLC (30% acetone in hexanes) Rf = 0.31; 1H NMR (400 MHz; CDCl3, isomeric ratio 11.5[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 9.57 (br s, 1H of major and minor isomers), 7.62–7.58 (m, 2H of major and minor isomers), 7.15–7.09 (m, 2H of major and minor isomers), 5.63 (s, 1.84H), 5.40* (s, 0.16H) ppm. 13C NMR (100 MHz; CDCl3) δ 164.0 (d, J = 249.9 Hz, C), 147.7 (d, J = 8.2 Hz, C), 130.6* (d, J = 8.5 Hz, 2 × CH), 129.1 (d, J = 3.1 Hz, C), 128.3 (d, J = 8.5 Hz, 2 × CH), 116.2 (d, J = 21.8 Hz, 2 × CH), 115.9* (d, J = 21.8 Hz, 2 × CH), 78.0* (CH2), 68.5 (CH2) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3279 (O–H), 1602 (C[double bond, length as m-dash]N), 1549 and 1376 (NO2) cm−1; HRMS (APCI-TOF) m/z calcd for C8H7FN2NaO3 [M + Na]+ 221.0338, found 221.0337.
1-(3-Fluorophenyl)-2-nitroethanone oxime (2f). Yellow viscous oil (74.2 mg, 75% yield); TLC (30% acetone in hexanes) Rf = 0.31; 1H NMR (400 MHz; CDCl3, isomeric ratio 32.3[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 8.71 (br s, 1H of major and minor isomers), 7.45–7.38 (m, 3H of major and minor isomers), 7.18–7.13 (m, 1H of major and minor isomers), 5.64 (s, 1.94H), 5.40* (s, 0.06H) ppm. 13C NMR (100 MHz; CDCl3) δ 163.0 (d, J = 245.8 Hz, C), 147.5 (d, J = 2.6 Hz, C), 135.1 (d, J = 7.9 Hz, C), 130.7 (d, J = 8.2 Hz, CH), 121.8 (d, J = 2.9 Hz, CH), 117.4 (d, J = 21.2 Hz, CH), 113.2 (d, J = 23.5 Hz, CH), 77.9* (CH2), 68.0 (CH2) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3274 (O–H), 1610 (C[double bond, length as m-dash]N), 1558 and 1376 (NO2) cm−1; MS m/z (%) relative intensity 199 (M+ + 1, 100), 198 (M+, 31), 180 (3), 121 (82), 109 (59); HRMS (APCI-TOF) calcd for C8H7FN2NaO3 [M + Na]+ 221.0338, found 221.0331.
1-(4-Nitrophenyl)-2-nitroethanone oxime (2g). Pale yellow solid (75.2 mg, 66% yield); mp = 123–124 °C (EtOAc/hexanes); TLC (30% acetone in hexanes) Rf = 0.21; 1H NMR (400 MHz; acetone-d6, isomeric ratio 19.0[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 11.99 (s, 1H of major and minor isomers), 8.23 (dd, J = 7.1, 2.0 Hz, 2H of major and minor isomers), 7.99 (dd, J = 7.1, 2.0 Hz, 2H of major and minor isomers), 5.89 (s, 1.90H), 5.68* (s, 0.10H) ppm. 13C NMR (100 MHz; acetone-d6) δ 149.0 (C), 147.4 (C), 141.0 (C), 130.6* (2 × CH), 127.7 (2 × CH), 124.4 (2 × CH), 124.0* (2 × CH), 78.6* (CH2), 68.4 (CH2) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3364 (O–H), 1599 (C[double bond, length as m-dash]N), 1567 and 1380 (NO2) cm−1; MS m/z (%) relative intensity 225 (M+, 2), 147 (100), 102 (33), 89 (98); HRMS (ESI-TOF) calcd for C8H7N3NaO5 [M + Na]+ 248.0283, found 248.0282.
1-(3-Nitrophenyl)-2-nitroethanone oxime (2h). Pale yellow solid (69.8 mg, 62% yield); mp = 98–99 °C (CH2Cl2/hexanes); TLC (30% acetone in hexanes) Rf = 0.26; 1H NMR (400 MHz; acetone-d6, isomeric ratio 21.2[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 11.93 (s, 0.95H), 11.51* (s, 0.05H), 8.63 (t, J = 1.7 Hz, 1H of major and minor isomers), 8.32–8.29 (m, 1H of major and minor isomers), 8.24–8.21 (m, 1H of major and minor isomers), 7.77 (t, J = 8.0 Hz, 1H of major and minor isomers), 6.00 (s, 1.91H), 5.81* (s, 0.09H) ppm. 13C NMR (100 MHz; acetone-d6) δ 149.5 (C), 147.5 (C), 137.0 (C), 135.6* (CH), 132.9 (CH), 131.0 (CH), 130.6* (CH), 125.0* (CH), 124.8 (CH), 124.4* (CH), 121.5 (CH), 78.7* (CH2), 68.8 (CH2) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3314 (O–H), 1575 (C[double bond, length as m-dash]N), 1533 and 1378 (NO2) cm−1; MS m/z (%) relative intensity 225 (M+, 1), 148 (100), 102 (56), 89 (41); HRMS (ESI-TOF) calcd for C8H7N3NaO5 [M + Na]+ 248.0283, found 248.0276.
3-(1-(Hydroxyimino)-2-nitroethyl)benzaldehyde (2i). Yellow solid (59.2 mg, 56% yield); mp = 118–119 °C (EtOAc/hexanes); TLC (30% acetone in hexanes) Rf = 0.19; 1H NMR (400 MHz; acetone-d6) δ 11.80 (s, 1H), 10.11 (s, 1H), 8.33 (t, J = 1.5 Hz, 1H), 8.13 (ddd, J = 7.8, 1.8, 1.2 Hz, 1H), 8.01 (dt, J = 7.6, 1.3 Hz, 1H), 7.71 (t, J = 7.7 Hz, 1H), 5.98 (s, 2H) ppm. 13C NMR (100 MHz; acetone-d6) δ 192.6 (CH), 148.0 (C), 137.9 (C), 136.2 (C), 132.3 (CH), 131.0 (CH), 130.3 (CH), 127.7 (CH), 68.8 (CH2) ppm; IR (KBr) ν 3203 (O–H), 1610 (C[double bond, length as m-dash]N), 1554 and 1381 (NO2) cm−1; MS m/z (%) relative intensity 208 (M+, 6), 131 (90), 103 (76), 77 (100); HRMS (ESI-TOF) calcd for C9H8N2NaO4 [M + Na]+ 231.0382, found 231.0375.
1-(4-(Chloromethyl)phenyl)-2-nitroethanone oxime (2j). Pale yellow solid (68.4 mg, 60% yield); mp = 83–84 °C (CH2Cl2/hexanes); TLC (30% acetone in hexanes) Rf = 0.24; 1H NMR (400 MHz; CDCl3) δ 8.76 (br s, 1H), 7.64 (d, J = 8.3 Hz, 2H), 7.46 (d, J = 8.3 Hz, 2H), 5.65 (s, 2H), 4.60 (s, 2H) ppm. 13C NMR (100 MHz; CDCl3) δ 148.0 (C), 139.7 (C), 133.0 (C), 129.2 (2 × CH), 126.5 (2 × CH), 68.1 (CH2), 45.4 (CH2) ppm; IR (KBr) ν 3227 (O–H), 1605 (C[double bond, length as m-dash]N), 1574 and 1383 (NO2) cm−1; MS m/z (%) relative intensity 228 (M+, 3), 151 (100), 115 (44), 100 (30); HRMS (APCI-TOF) calcd for C9H10ClN2O3 [M + H]+ 229.0380, found 229.0375.
2-Nitro-1-(p-tolyl)ethanone oxime (2k)8a. Yellow viscous oil (43.9 mg, 45% yield); TLC (30% acetone in hexanes) Rf = 0.36; 1H NMR (400 MHz; CDCl3, isomeric ratio 10.8[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 9.37 (br s, 1H of major and minor isomers), 7.42 (d, J = 8.1 Hz, 2H of major and minor isomers), 7.15 (d, J = 8.1 Hz, 2H of major and minor isomers), 5.56 (s, 1.83H), 5.31* (s, 0.17H), 2.30 (s, 3H of major and minor isomers) ppm. 13C NMR (100 MHz; CDCl3) δ 148.5 (C), 140.9 (C), 131.3* (C), 130.0 (C), 129.8 (2 × CH), 129.4* (2 × CH), 129.0* (C), 128.3* (2 × CH), 126.8* (C), 126.1 (2 × CH), 78.1* (CH2), 68.5 (CH2), 21.5* (CH3), 21.4 (CH3) ppm; IR (KBr) ν 3292 (O–H), 1611 (C[double bond, length as m-dash]N), 1546 and 1377 (NO2) cm−1; HRMS (ESI-TOF) m/z calcd for C9H10N2NaO3 [M + Na]+ 217.0589, found 217.0595.
1-(4-Methoxyphenyl)-2-nitroethanone oxime (2l)8a. Pale yellow solid (56.0 mg, 51% yield); mp = 109–110 °C (CH2Cl2/hexanes); TLC (20% acetone in hexanes) Rf = 0.26; 1H NMR (400 MHz; acetone-d6) δ 11.22 (s, 1H), 7.72 (dd, J = 6.9, 2.2 Hz, 2H), 6.98 (dd, J = 6.9, 2.2 Hz, 2H), 5.84 (s, 2H), 3.83 (s, 3H) ppm. 13C NMR (100 MHz; acetone-d6) δ 161.7 (C), 148.2 (C), 128.2 (2 × CH), 127.5 (C), 114.8 (2 × CH), 68.9 (CH2), 55.6 (CH3) ppm; IR (KBr) ν 3229 (O–H), 1606 (C[double bond, length as m-dash]N), 1559 and 1380 (NO2) cm−1; HRMS (ESI-TOF) m/z calcd for C9H11N2O4 [M + H]+ 211.0719, found 211.0720.
1-(4-(tert-Butyl)phenyl)-2-nitroethanone oxime (2m). Yellow solid (70.3 mg, 59% yield); mp = 102–103 °C (CH2Cl2/hexanes); TLC (30% acetone in hexanes) Rf = 0.32; 1H NMR (400 MHz; CDCl3, isomeric ratio 5.5[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 9.27 (br s, 0.85H), 8.81* (br s, 0.15H), 7.57 (d, J = 8.5 Hz, 2H of major and minor isomers), 7.46 (d, J = 8.5 Hz, 2H of major and minor isomers), 5.66 (s, 1.69H), 5.41* (s, 0.31H), 1.33 (br s, 9H of major and minor isomers) ppm. 13C NMR (100 MHz; CDCl3) δ 153.9 (C), 148.4 (C), 130.0 (C), 128.1* (2 × CH), 126.1 (2 × CH), 125.9 (2 × CH), 125.7* (2 × CH), 78.1* (CH2), 68.4 (CH2), 34.9 (C), 31.1 (3 × CH3) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3300 (O–H), 1608 (C[double bond, length as m-dash]N), 1558 and 1374 (NO2) cm−1; MS m/z (%) relative intensity 236 (M+, 6), 221 (52), 175 (35), 158 (100), 130 (40); HRMS (ESI-TOF) calcd for C12H16N2NaO3 [M + Na]+ 259.1059, found 259.1058.
4-(1-(Hydroxyimino)-2-nitroethyl)phenyl acetate (2n). Yellow solid (85.7 mg, 71% yield); mp = 114–115 °C (EtOAc/hexanes); TLC (30% acetone in hexanes) Rf = 0.20; 1H NMR (400 MHz; acetone-d6, isomeric ratio 14.4[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 11.35 (s, 1H of major and minor isomers), 7.63 (d, J = 8.3 Hz, 2H of major and minor isomers), 7.03 (d, J = 8.3 Hz, 2H of major and minor isomers), 5.66 (br s, 1.87H), 5.44* (br s, 0.13H), 2.14 (br s, 3H of major and minor isomers) ppm. 13C NMR (100 MHz; acetone-d6) δ 169.5 (C), 152.9 (C), 148.0 (C), 132.6 (C), 130.7* (2 × CH), 128.0 (2 × CH), 122.9 (2 × CH), 122.5* (2 × CH), 79.2* (CH2), 69.0 (CH2), 20.9 (CH3) ppm (some peaks of the minor isomer could not be detected by 13C NMR due to their low intensity); IR (KBr) ν 3278 (O–H), 1604 (C[double bond, length as m-dash]N), 1570 and 1369 (NO2) cm−1; MS m/z (%) relative intensity 238 (M+, 7), 196 (21), 119 (31), 107 (100), 77 (25); HRMS (ESI-TOF) calcd for C10H10N2NaO5 [M + Na]+ 261.0487, found 261.0480.
2-Nitro-1-phenylethanone oxime (2o)13. Yellow solid (59.1 mg, 63% yield); mp = 95–96 °C (CH2Cl2/hexanes, lit.13 mp 95 °C); TLC (30% acetone in hexanes) Rf = 0.24; 1H NMR (400 MHz; CDCl3) δ 8.65 (br s, 1H), 7.65–7.63 (m, 2H), 7.47–7.43 (m, 3H), 5.66 (s, 2H) ppm. 13C NMR (100 MHz; CDCl3) δ 148.5 (C), 133.0 (C), 130.4 (CH), 129.0 (2 × CH), 126.2 (2 × CH), 68.3 (CH2) ppm; IR (KBr) ν 3222 (O–H), 1636 (C[double bond, length as m-dash]N), 1559 and 1383 (NO2) cm−1; MS m/z (%) relative intensity 180 (M+, 3), 134 (11), 103 (100), 91 (65), 77 (42); HRMS (ESI-TOF) calcd for C8H8N2NaO3 [M + Na]+ 203.0433, found 203.0434.
1-(Naphthalen-1-yl)-2-nitroethanone oxime (2p). Yellow viscous oil (51.1 mg, 44% yield); TLC (30% acetone in hexanes) Rf = 0.22; 1H NMR (400 MHz; CDCl3, isomeric ratio 1.7[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 9.61 (br s, 0.63H), 8.84* (br s, 0.37H), 8.01–7.88 (m, 3H of major and minor isomers), 7.68–7.37 (m, 4H of major and minor isomers), 5.63 (s, 1.26H), 5.46* (s, 0.74H) ppm. 13C NMR (100 MHz; CDCl3) δ 149.3* (C), 149.1 (C), 133.8 (C), 133.5* (C), 130.83 (C), 130.79* (C), 130.6 (CH), 130.5* (CH), 129.4 (C), 128.8 (CH), 128.7* (CH), 127.4* (CH), 127.3 (CH), 127.1* (CH), 126.9* (C), 126.57* (CH), 126.55 (CH), 125.4 (CH), 125.20 (CH), 125.18* (CH), 125.1* (CH), 124.5 (CH), 79.0* (CH2), 71.6 (CH2) ppm; IR (neat) ν 3273 (O–H), 1592 (C[double bond, length as m-dash]N), 1558 and 1372 (NO2) cm−1; MS m/z (%) relative intensity 230 (M+, 14), 184 (31), 166 (100), 152 (47), 115 (19); HRMS (ESI-TOF) calcd for C12H10N2NaO3 [M + Na]+ 253.0589, found 253.0588.
2-Nitro-1-phenylpropan-1-one oxime (2q). Yellow solid (50.5 mg, 52% yield); mp = 96–97 °C (EtOAc/hexanes); TLC (30% acetone in hexanes) Rf = 0.29; 1H NMR (400 MHz; acetone-d6, isomeric ratio 2.3[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 11.29 (s, 0.70H), 10.86* (s, 0.30H), 7.64–7.39 (m, 5H of major and minor isomers), 6.10 (q, J = 6.9 Hz, 0.70H), 5.82* (q, J = 6.9 Hz, 0.30H), 1.86 (d, J = 6.9 Hz, 2.09H), 1.75* (d, J = 6.9 Hz, 0.91H) ppm. 13C NMR (100 MHz; acetone-d6) δ 153.3 (C), 152.3* (C), 134.8 (C), 132.1*(C), 130.2 (CH), 130.0* (CH), 129.4 (2 × CH), 129.1* (2 × CH), 129.0* (2 × CH), 127.4 (2 × CH), 86.2* (CH), 78.3 (CH), 17.1* (CH3), 15.4 (CH3) ppm; IR (KBr) ν 3237 (O–H), 1648 (C[double bond, length as m-dash]N), 1546 and 1386 (NO2) cm−1; MS m/z (%) relative intensity 194 (M+, 2), 130 (26), 117 (70), 115 (100), 103 (32), 77 (65); HRMS (ESI-TOF) calcd for C9H10N2NaO3 [M + Na]+ 217.0589, found 217.0587.
2-Nitro-3,4-dihydronaphthalen-1(2H)-one oxime (2r)14. Pale brown solid (57.7 mg, 56%); mp = 138–139 °C (CH2Cl2/hexanes, lit.14 mp 140–142 °C); TLC (20% acetone in hexanes) Rf = 0.28; 1H NMR (400 MHz; CDCl3) δ 11.86 (br s, 1H), 10.61 (d, J = 7.9 Hz, 1H), 9.82–9.62 (m, 2H), 9.58 (d, J = 7.5 Hz, 1H), 8.09 (t, J = 4.7 Hz, 1H), 3.93–3.79 (m, 1H), 3.76–3.68 (m, 1H), 3.59–3.50 (m, 1H), 3.16–3.03 (m, 1H). 13C NMR (100 MHz; CDCl3) δ 147.8 (C), 137.4 (C), 130.3 (CH), 128.7 (CH), 128.1 (C), 127.3 (CH), 124.5 (CH), 76.9 (CH), 27.8 (CH2), 25.0 (CH2); IR (KBr) ν 3300 (O–H), 1598 (C[double bond, length as m-dash]N), 1547 and 1375 (NO2) cm−1; MS m/z (%) relative intensity 206 (M+, 1), 160 (10), 142 (23), 128 (36), 115 (100), 89 (31); HRMS (ESI-TOF) calcd for C10H10N2NaO3 [M + Na]+ 229.0589, found 229.0584.
2-Nitro-1-(thiophen-2-yl)ethanone oxime (2s)15. Yellow solid (51.2 mg, 73%); mp = 218–219 °C (CH2Cl2/hexanes, lit.15 mp 218 °C); TLC (30% acetone in hexanes) Rf = 0.38; 1H NMR (400 MHz; CDCl3, isomeric ratio 1[thin space (1/6-em)]:[thin space (1/6-em)]1, minor isomer marked*) δ 9.29 (br s, 0.53H), 7.65 (d, J = 4.8 Hz, 0.51H), 7.48 (d, J = 3.9 Hz, 0.54H), 7.38* (d, J = 4.8 Hz, 0.49H), 7.28* (d, J = 3.9 Hz, 0.47H), 7.13 (dd, J = 4.8, 3.9 Hz, 0.54H), 7.07* (dd, J = 4.8, 3.9 Hz, 0.49H), 5.64 (s, 0.93H), 5.54 (s, 1H) (some peaks of the minor isomer could not be detected by 1H NMR due to their low intensity). 13C NMR (75 MHz; CDCl3) δ 144.3* (C), 142.4 (C), 136.6* (C), 132.3* (CH), 129.6 (C), 129.4 (CH), 128.6* (CH), 127.6 (CH), 127.4* (CH), 126.2 (CH), 77.4 (CH2), 68.0* (CH2); IR (KBr) ν 3265 (O–H), 1637 (C[double bond, length as m-dash]N), 1557 and 1375 (NO2) cm−1; MS m/z (%) relative intensity 186 (M+, 11), 140 (14), 109 (37), 97 (100); HRMS (ESI-TOF) calcd for C6H6N2NaO3S [M + Na]+ 208.9997, found 208.9996.

Acknowledgements

We thank the Thailand Research Fund (TRF-DBG5480017), the Center of Excellence for Innovation in Chemistry (PERCH-CIC), the Office of the Higher Education Commission, Mahidol University under the National Research Universities Initiative for financial support.

Notes and references

  1. For selected dioxygenation, see: (a) C. J. R. Bataille and T. J. Donohoe, Chem. Soc. Rev., 2011, 40, 114 RSC; (b) Q. Xue, J. Xie, P. Xu, K. Hu, Y. Cheng and C. Zhu, ACS Catal., 2013, 3, 1365 CrossRef CAS; (c) M. J. Rawling and N. C. O. Tomkinson, Org. Biomol. Chem., 2013, 11, 1434 RSC; (d) B. C. Giglio, V. A. Schmidt and E. J. Alexanian, J. Am. Chem. Soc., 2011, 133, 13320 CrossRef CAS PubMed; (e) M.-K. Zhu, J.-F. Zhao and T.-P. Loh, J. Am. Chem. Soc., 2010, 132, 6284 CrossRef CAS PubMed; (f) A. Wang, H. Jiang and H. Chen, J. Am. Chem. Soc., 2009, 131, 3846 CrossRef CAS PubMed; (g) Y. Li, D. Song and V. M. Dong, J. Am. Chem. Soc., 2008, 130, 2962 CrossRef CAS PubMed.
  2. For selected oxyamination, see: (a) Masruri, A. C. Willis and M. D. McLeod, J. Org. Chem., 2012, 77, 8480 CrossRef CAS PubMed; (b) F. C. Sequeira and S. R. Chemler, Org. Lett., 2012, 14, 4482 CrossRef CAS PubMed; (c) K. S. Williamson and T. P. Yoon, J. Am. Chem. Soc., 2012, 134, 12370 CrossRef CAS PubMed; (d) U. Farid and T. Wirth, Angew. Chem., Int. Ed., 2012, 51, 3462 CrossRef CAS PubMed; (e) T. de Haro and C. Nevado, Angew. Chem., Int. Ed., 2011, 50, 906 CrossRef CAS PubMed; (f) T. J. Donohoe, C. K. A. Callens, A. Flores, A. R. Lacy and A. H. Rathi, Chem.–Eur. J., 2011, 17, 58 CrossRef CAS PubMed; (g) D. E. Mancheno, A. R. Thornton, A. H. Stoll, A. Kong and S. B. Blakey, Org. Lett., 2010, 12, 4110 CrossRef CAS PubMed; (h) D. J. Michaelis, C. J. Shaffer and T. P. Yoon, J. Am. Chem. Soc., 2007, 129, 1866 CrossRef CAS PubMed; (i) E. J. Alexanian, C. Lee and E. J. Sorensen, J. Am. Chem. Soc., 2005, 127, 7690 CrossRef CAS PubMed.
  3. For selected oxysulfonylation and oxysulfenylation, see: (a) F.-L. Yang, F.-X. Wang, T.-T. Wang, Y.-J. Wang and S.-K. Tian, Chem. Commun., 2014, 50, 2111 RSC; (b) R. Chawla, A. K. Singh and L. D. S. Yadav, Eur. J. Org. Chem., 2014, 2032 CrossRef CAS; (c) A. Kariya, T. Yamaguchi, T. Nobuta, N. Tada, T. Miura and A. Itoh, RSC Adv., 2014, 4, 13191 RSC; (d) Q. Lu, J. Zhang, F. Wei, Y. Qi, H. Wang, Z. Liu and A. Lei, Angew. Chem., Int. Ed., 2013, 52, 7156 CrossRef CAS PubMed; (e) W. Wei, C. Liu, D. Yang, J. Wen, J. You, Y. Suo and H. Wang, Chem. Commun., 2013, 49, 10239 RSC; (f) T. Taniguchi, A. Idota and H. Ishibashi, Org. Biomol. Chem., 2011, 9, 3151 RSC.
  4. W. Wei and J.-X. Ji, Angew. Chem., Int. Ed., 2011, 50, 9097 CrossRef CAS PubMed.
  5. For selected diamination, see: (a) B. W. Turnpenny and S. R. Chemler, Chem. Sci., 2014, 5, 1786 RSC; (b) E. L. Ingalls, P. A. Sibbald, W. Kaminsky and F. E. Michael, J. Am. Chem. Soc., 2013, 135, 8854 CrossRef CAS PubMed; (c) M.-K. Zhu, Y.-C. Chen and T.-P. Loh, Chem.–Eur. J., 2013, 19, 5250 CrossRef CAS PubMed; (d) C. Röben, J. A. Souto, E. C. Escudero-Adán and K. Muñiz, Org. Lett., 2013, 15, 1008 CrossRef PubMed; (e) K. Muñiz and C. Martínez, J. Org. Chem., 2013, 78, 2168 CrossRef PubMed; (f) H. J. Kim, S. H. Cho and S. Chang, Org. Lett., 2012, 14, 1424 CrossRef CAS PubMed.
  6. (a) E. Bogatcheva, C. Hanrahan, B. Nikonenko, R. Samala, P. Chen, J. Gearhart, F. Barbosa, L. Einck, C. A. Nacy and M. Protopopova, J. Med. Chem., 2006, 49, 3045 CrossRef CAS PubMed; (b) D. Lucet, T. Le Gall and C. Mioskowski, Angew. Chem., Int. Ed., 1998, 37, 2580 CrossRef CAS; (c) W. Notz, F. Tanaka and C. F. Barbas III, Acc. Chem. Res., 2004, 37, 580 CrossRef CAS PubMed; (d) I.-W. Kim and S.-H. Jung, Arch. Pharmacal Res., 2002, 25, 421 CrossRef CAS.
  7. (a) S. Prateeptongkum, I. Jovel, R. Jackstell, N. C. Weckbecker and M. Beller, Chem. Commun., 2009, 1990 RSC; (b) K. Sugamoto, Y. Hamasuna, Y. Matsushita and T. Matsui, Synlett, 1998, 1270 CrossRef CAS PubMed; (c) K. Kato and T. Mukaiyama, Chem. Lett., 1992, 21, 1137 CrossRef; (d) K. Kato and T. Mukaiyama, Bull. Chem. Soc. Jpn., 1991, 64, 2948 CrossRef CAS; (e) K. Kato and T. Mukaiyama, Chem. Lett., 1990, 19, 1395 CrossRef; (f) K. Kato and T. Mukaiyama, Chem. Lett., 1990, 19, 1917 CrossRef; (g) T. Okamoto, K. Kobayashi, S. Oka and S. Tanimoto, J. Org. Chem., 1988, 53, 4897 CrossRef CAS; (h) T. Okamoto, K. Kobayashi, S. Oka and S. Tanimoto, J. Org. Chem., 1987, 52, 5089 CrossRef CAS.
  8. (a) A. Shaabani, H. R. Bijanzadeh, A. R. Karimi, M. B. Teimouri and K. Soleimani, Can. J. Chem., 2008, 86, 248 CrossRef CAS; (b) L. Grossi, P. C. Montevecchi and S. Strazzari, Eur. J. Org. Chem., 2001, 741 CrossRef CAS; (c) M. L. Scheinbaum, J. Org. Chem., 1970, 35, 2790 CrossRef CAS.
  9. R. M. Uppu and W. A. Pryor, Anal. Biochem., 1996, 236, 242 CrossRef CAS PubMed.
  10. (a) C. Muangkaew, P. Katrun, P. Kanchanarugee, M. Pohmakotr, V. Reutrakul, D. Soorukram, T. Jaipetch and C. Kuhakarn, Tetrahedron, 2013, 69, 8847 CrossRef CAS PubMed; (b) T. Sawangphon, P. Katrun, K. Chaisiwamongkhol, M. Pohmakotr, V. Reutrakul, D. Soorukram, T. Jaipetch and C. Kuhakarn, Synth. Commun., 2013, 43, 1692 CrossRef CAS; (c) N. Samakkanad, P. Katrun, T. Techajaroonjit, S. Hlekhlai, M. Pohmakotr, V. Reutrakul, T. Jaipetch, D. Soorukram and C. Kuhakarn, Synthesis, 2012, 44, 1693 CrossRef CAS PubMed; (d) P. Katrun, S. Chiampanichayakul, K. Korworapan, M. Pohmakotr, V. Reutrakul, D. Soorukram, T. Jaipetch and C. Kuhakarn, Eur. J. Org. Chem., 2010, 5633 CrossRef CAS.
  11. (a) M. C. Marcotullio, F. Epifano and M. Curini, Trends Org. Chem., 2003, 10, 21 CAS; (b) K. Moriyama, M. Takemura and H. Togo, Org. Lett., 2012, 14, 2414 CrossRef CAS PubMed; (c) B. Yu, A.-H. Liu, L.-N. He, B. Li, Z.-F. Diao and Y.-N. Li, Green Chem., 2012, 14, 957 RSC; (d) H. Hussain, I. R. Green and I. Ahmed, Chem. Rev., 2013, 113, 3329 CrossRef CAS PubMed; (e) A. Yoshimura, K. R. Middleton, A. D. Todora, B. J. Kastern, S. R. Koski, A. V. Maskaev and V. V. Zhdankin, Org. Lett., 2013, 15, 4010 CrossRef CAS PubMed; (f) B. Poladura, A. Martinez-Castaneda, H. Rodriguez-Solla, R. Llavona, C. Concellon and V. del Amo, Org. Lett., 2013, 15, 2810 CrossRef CAS PubMed; (g) F. Drouet, G. Masson and J. Zhu, Org. Lett., 2013, 15, 2854 CrossRef CAS PubMed; (h) A. C. Nelson, E. S. Kalinowski, N. J. Czerniecki, T. L. Jacobson and P. Grundt, Org. Biomol. Chem., 2013, 11, 7455 RSC; (i) X.-L. Lian, H. Lei, X.-J. Quan, Z.-H. Ren, Y.-Y. Wang and Z.-H. Guan, Chem. Commun., 2013, 49, 8196 RSC.
  12. (a) H. Baji, M. Flammang, T. Kimny, F. Gasquez, P. L. Compagnon and A. Delcourt, Eur. J. Med. Chem., 1995, 30, 617 CrossRef CAS; (b) A. Balsamo, M. C. Breschi, G. Chielini, L. Favero, M. Macchia, A. Martinelli, C. Martini, A. Rossello and R. Scatizzi, Eur. J. Med. Chem., 1995, 30, 743 CrossRef CAS; (c) A. Karakurt, M. A. Alagöz, B. Sayoǧlu, Ü. Çaliş and S. Dalkara, Eur. J. Med. Chem., 2012, 57, 275 CrossRef CAS PubMed.
  13. E. Duranti, C. Balsamini, G. Spadoni and S. Lamberto, J. Org. Chem., 1988, 53, 2870 CrossRef CAS.
  14. T. Kametani, H. Sugahara and H. Yagi, J. Chem. Soc. C, 1966, 7, 717 RSC.
  15. P. Fournari and J. P. Chane, Bull. Soc. Chim. Fr., 1963, 479 CAS.

Footnote

Electronic supplementary information (ESI) available. See DOI: 10.1039/c4ra11703d

This journal is © The Royal Society of Chemistry 2014
Click here to see how this site uses Cookies. View our privacy policy here.